Lifshitz Law PLLC Announces Investigations of GRNA, AAIC, EMBK, and REUN
NEW YORK, June 03, 2023 (GLOBE NEWSWIRE) --
GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA)
Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of GRNA to a group of buyers led by Fall Line Capital, LLC for $0.30 per share in cash.
If you are a GRNA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Arlington Asset Investment Corp. (NYSE:AAIC)
Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of AAIC and Ellington Financial Inc. Under the terms of the proposed merger, (i) AAIC shareholders will receive 0.3619 shares of Ellington Financial Inc. common stock for each share of AAIC common stock owned; and (ii) AAIC shareholders will also receive $0.09 in cash per share. Following the merger, pre-merger Arlington shareholders are expected to own approximately 15% of the outstanding equity of the combined company.
If you are an AAIC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Embark Technology, Inc. (NASDAQ:EMBK)
Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of EMBK to Applied Intuition, Inc. for $2.88 per share in cash.
If you are an EMBK investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Reunion Neuroscience, Inc. (NASDAQ:REUN)
Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of REUN to affiliates of MPM BioImpact for $1.12 per share in cash.
If you are a REUN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
ATTORNEY ADVERTISING.© 2023 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: [email protected]
